Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study
Repeat DCB therapy for DCB restenosis might be an acceptable strategy, particularly for restenosis that occurred more than 12.6 months after initial DCB, given the rate of freedom from recurrent restenosis.
Authors
- Satoaki Matoba (ORCID: https://orcid.org/0000-0002-9373-4331)
- Keita Hirano (ORCID: https://orcid.org/0000-0003-3695-9056)
- Takashi Yanagiuchi (ORCID: https://orcid.org/0000-0001-5179-1277)
- Kuniyoshi Fukai (ORCID: https://orcid.org/0000-0001-5906-658X)
- H. Yokoi (ORCID: https://orcid.org/0000-0002-2657-8164)
- Taku Kato (ORCID: https://orcid.org/0000-0002-9396-3564)
- Kan Zen (ORCID: https://orcid.org/0000-0003-1229-4328)
- Yoshihiro Iwasaki
- Koji Sogabe
Institutions
- Kyoto University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Rakuwakai Otowa Hospital (JP)
- Kyoto first Red Cross hospital (JP)
- Kyoto Katsura Hospital (JP)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1002/ccd.31245
- Citations
- 2
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 1.15